81 related articles for article (PubMed ID: 17210706)
1. Multidrug resistance protein 4 protects bone marrow, thymus, spleen, and intestine from nucleotide analogue-induced damage.
Belinsky MG; Guo P; Lee K; Zhou F; Kotova E; Grinberg A; Westphal H; Shchaveleva I; Klein-Szanto A; Gallo JM; Kruh GD
Cancer Res; 2007 Jan; 67(1):262-8. PubMed ID: 17210706
[TBL] [Abstract][Full Text] [Related]
2. 6-mercaptopurine and 9-(2-phosphonyl-methoxyethyl) adenine (PMEA) transport altered by two missense mutations in the drug transporter gene ABCC4.
Janke D; Mehralivand S; Strand D; Gödtel-Armbrust U; Habermeier A; Gradhand U; Fischer C; Toliat MR; Fritz P; Zanger UM; Schwab M; Fromm MF; Nürnberg P; Wojnowski L; Closs EI; Lang T
Hum Mutat; 2008 May; 29(5):659-69. PubMed ID: 18300232
[TBL] [Abstract][Full Text] [Related]
3. Functional involvement of multidrug resistance-associated protein 4 (MRP4/ABCC4) in the renal elimination of the antiviral drugs adefovir and tenofovir.
Imaoka T; Kusuhara H; Adachi M; Schuetz JD; Takeuchi K; Sugiyama Y
Mol Pharmacol; 2007 Feb; 71(2):619-27. PubMed ID: 17110501
[TBL] [Abstract][Full Text] [Related]
4. MRP4: A previously unidentified factor in resistance to nucleoside-based antiviral drugs.
Schuetz JD; Connelly MC; Sun D; Paibir SG; Flynn PM; Srinivas RV; Kumar A; Fridland A
Nat Med; 1999 Sep; 5(9):1048-51. PubMed ID: 10470083
[TBL] [Abstract][Full Text] [Related]
5. Down-regulation of Na+/H+ exchanger regulatory factor 1 increases expression and function of multidrug resistance protein 4.
Hoque MT; Cole SP
Cancer Res; 2008 Jun; 68(12):4802-9. PubMed ID: 18559527
[TBL] [Abstract][Full Text] [Related]
6. Multidrug resistance protein (MRP) 4- and MRP 5-mediated efflux of 9-(2-phosphonylmethoxyethyl)adenine by microglia.
Dallas S; Schlichter L; Bendayan R
J Pharmacol Exp Ther; 2004 Jun; 309(3):1221-9. PubMed ID: 14762102
[TBL] [Abstract][Full Text] [Related]
7. Substrate overlap between Mrp4 and Abcg2/Bcrp affects purine analogue drug cytotoxicity and tissue distribution.
Takenaka K; Morgan JA; Scheffer GL; Adachi M; Stewart CF; Sun D; Leggas M; Ejendal KF; Hrycyna CA; Schuetz JD
Cancer Res; 2007 Jul; 67(14):6965-72. PubMed ID: 17638908
[TBL] [Abstract][Full Text] [Related]
8. Enhanced 9-(2-phosphonylmethoxyethyl)adenine secretion by a specific, indomethacin-sensitive efflux pump in a mutant 9-(2-phosphonylmethoxyethyl)adenine-resistant human erythroleukemia K562 cell line.
Hatse S; De Clercq E; Balzarini J
Mol Pharmacol; 1998 Nov; 54(5):907-17. PubMed ID: 9804626
[TBL] [Abstract][Full Text] [Related]
9. Human immunodeficiency virus protease inhibitors interact with ATP binding cassette transporter 4/multidrug resistance protein 4: a basis for unanticipated enhanced cytotoxicity.
Fukuda Y; Takenaka K; Sparreboom A; Cheepala SB; Wu CP; Ekins S; Ambudkar SV; Schuetz JD
Mol Pharmacol; 2013 Sep; 84(3):361-71. PubMed ID: 23775562
[TBL] [Abstract][Full Text] [Related]
10. Chemotherapy and chemosensitization of transgenic mice which express the human multidrug resistance gene in bone marrow: efficacy, potency, and toxicity.
Mickisch GH; Licht T; Merlino GT; Gottesman MM; Pastan I
Cancer Res; 1991 Oct; 51(19):5417-24. PubMed ID: 1680550
[TBL] [Abstract][Full Text] [Related]
11. A human T lymphoid cell variant resistant to the acyclic nucleoside phosphonate 9-(2-phosphonylmethoxyethyl)adenine shows a unique combination of a phosphorylation defect and increased efflux of the agent.
Robbins BL; Connelly MC; Marshall DR; Srinivas RV; Fridland A
Mol Pharmacol; 1995 Feb; 47(2):391-7. PubMed ID: 7870049
[TBL] [Abstract][Full Text] [Related]
12. Immunomodulatory activity of 9-(2-phosphonylmethoxyethyl)adenine (PMEA), a potent anti-HIV nucleotide analogue, on in vivo murine models.
Del Gobbo V; Foli A; Balzarini J; De Clercq E; Balestra E; Villani N; Marini S; Perno CF; Calio R
Antiviral Res; 1991 Jul; 16(1):65-75. PubMed ID: 1723264
[TBL] [Abstract][Full Text] [Related]
13. Contribution of Abcc10 (Mrp7) to in vivo paclitaxel resistance as assessed in Abcc10(-/-) mice.
Hopper-Borge EA; Churchill T; Paulose C; Nicolas E; Jacobs JD; Ngo O; Kuang Y; Grinberg A; Westphal H; Chen ZS; Klein-Szanto AJ; Belinsky MG; Kruh GD
Cancer Res; 2011 May; 71(10):3649-57. PubMed ID: 21576088
[TBL] [Abstract][Full Text] [Related]
14. Analysis of the MRP4 drug resistance profile in transfected NIH3T3 cells.
Lee K; Klein-Szanto AJ; Kruh GD
J Natl Cancer Inst; 2000 Dec; 92(23):1934-40. PubMed ID: 11106685
[TBL] [Abstract][Full Text] [Related]
15. Role of basolateral efflux transporter MRP4 in the intestinal absorption of the antiviral drug adefovir dipivoxil.
Ming X; Thakker DR
Biochem Pharmacol; 2010 Feb; 79(3):455-62. PubMed ID: 19735648
[TBL] [Abstract][Full Text] [Related]
16. The human multidrug resistance protein 4 (MRP4, ABCC4): functional analysis of a highly polymorphic gene.
Abla N; Chinn LW; Nakamura T; Liu L; Huang CC; Johns SJ; Kawamoto M; Stryke D; Taylor TR; Ferrin TE; Giacomini KM; Kroetz DL
J Pharmacol Exp Ther; 2008 Jun; 325(3):859-68. PubMed ID: 18364470
[TBL] [Abstract][Full Text] [Related]
17. Analysis of methotrexate and folate transport by multidrug resistance protein 4 (ABCC4): MRP4 is a component of the methotrexate efflux system.
Chen ZS; Lee K; Walther S; Raftogianis RB; Kuwano M; Zeng H; Kruh GD
Cancer Res; 2002 Jun; 62(11):3144-50. PubMed ID: 12036927
[TBL] [Abstract][Full Text] [Related]
18. Na⁺/H⁺ exchanger regulatory factor 3 is critical for multidrug resistance protein 4-mediated drug efflux in the kidney.
Park J; Kwak JO; Riederer B; Seidler U; Cole SP; Lee HJ; Lee MG
J Am Soc Nephrol; 2014 Apr; 25(4):726-36. PubMed ID: 24436471
[TBL] [Abstract][Full Text] [Related]
19. MRP8, ATP-binding cassette C11 (ABCC11), is a cyclic nucleotide efflux pump and a resistance factor for fluoropyrimidines 2',3'-dideoxycytidine and 9'-(2'-phosphonylmethoxyethyl)adenine.
Guo Y; Kotova E; Chen ZS; Lee K; Hopper-Borge E; Belinsky MG; Kruh GD
J Biol Chem; 2003 Aug; 278(32):29509-14. PubMed ID: 12764137
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics in mice of the anti-retrovirus agent 9-(2-phosphonylmethoxyethyl)adenine.
Naesens L; Balzarini J; De Clercq E
Drug Metab Dispos; 1992; 20(5):747-52. PubMed ID: 1358582
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
